Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: UTD1 Injection plus capecitabine|DRUG: Capecitabine
Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd.